Studies related to Appetite and Cannabis

Comparison Of Orally Administered Cannabis Extract And Delta-9-tetrahydrocannabinol In Treating Patients With Cancer-related Anorexia-cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-blind, Placebo-controlled Clinical Trial From The Cannabis-In-Cachexia-Study-Group

Effect None
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 164
Sex Both Genders
Age Range 30-44, 45-64, 65+
Notes for this study:
Participants either received capsules containing a placebo, 2.5 mg THC and 1 mg CBD, or only 2.5 mg THC to be taken twice daily for six weeks. The primary outcome was appetite, measured using a visual analogue scale, and quality of life, measured using two quality of life questionnaires. Each outcome was measured every two weeks.

Full details on all 3 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.